Premium
THE USE OF UROKINASE IN SCRIBNER SHUNTS
Author(s) -
HARTLEY L. C. J.,
ELLIS F. G.,
RENDALL MAX,
CAMERON J. S.,
OGG C. S.
Publication year - 1970
Publication title -
british journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 0007-1331
DOI - 10.1111/j.1464-410x.1970.tb10030.x
Subject(s) - urokinase , shunt (medical) , medicine , dialysis , surgery
SUMMARY In the management of clotting in Scribner shunts, urokinase was of value in removing clot and thereby extending shunt life. During a trial involving 16 shunts over 40.5 patient months, no significant benefit was detected from the introduction of urokinase into the venous side of the shunt prior to each dialysis.